Home / PHARM.AS : AMS

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PHARM.AS make money? Does PHARM.AS have pricing power? What's the Earnings Whisper? Will PHARM.AS profit more as the business scales? What is PHARM.AS's management track record? Is PHARM.AS's current price justified?

Pharming Group N.V.

€0.84 -$0.62 (-42.60%)

AMS · 16 Oct 2026 15:35 UTC

Previous Close

€0.86

Day Range

€0.84€0.87

Year Range

€0.83€1.82

Market Cap

593.12M

AVG Volume

8.53M

Trailing/Forward PE

63.89/39.94

PEG ratio

0.1

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

Euronext Amsterdam

Revenue (USD) · A

PHARM.AS Revenue (USD) by year
Period	Revenue (USD)
2025	377.08M
2024	297.35M
2023	245.32M
2022	205.62M
2021	195.46M
2020	185.69M
2019	189.33M
2018	144.18M
2017	92.97M
2016	16.23M

Net Income (USD) · A

PHARM.AS Net Income (USD) by year
Period	Net Income (USD)
2025	2.87M
2024	-11.81M
2023	-10.55M
2022	13.67M
2021	15.76M
2020	35.3M
2019	40.14M
2018	29.07M
2017	-93.31M
2016	-18.44M

Operating Income (USD) · A

PHARM.AS Operating Income (USD) by year
Period	Operating Income (USD)
2025	21.65M
2024	-10.27M
2023	-5.39M
2022	18.23M
2021	18.78M
2020	60.02M
2019	67.44M
2018	38.09M
2017	21.12M
2016	-12.38M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (USD) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Pharming Group N.V.

Video analysis: PHARM.AS

News: PHARM.AS

Similar companies